Project Grant R21CA302024
Award Date 6/1/26
Completion Date 5/31/28
Dollars Obligated $408K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
- Federal Grant Award Summary Temple University received a $522,235 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), effective June 1, 2026 through May 31, 2031. This research initiative delivers a mixed-methods investigation examining how psychosocial stress, social group identification, and micro-social network dynamics shape tobacco use trajectories and cessation outcomes in emerging adults aged 18-26. The project...
- Federal Grant Award Summary Training to Prevent Anal Cancer (TPAC) Emory University received a $165,271 Project Grant award from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398) on August 26, 2025, with a completion date of July 31, 2027. This award supports the development, piloting, and evaluation of an innovative skills development program designed to train current women's health providers, infectious disease specialists, colorectal surgeons, and...
- Federal Grant Award Summary The Medical University of South Carolina received a $181,007 Project Grant from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398) on August 12, 2025, with completion targeted for July 31, 2027. This award supports a mixed-methods research initiative to assess decisional needs and develop health communication interventions for anal cancer screening among people with HIV (PWH). The project addresses significant gaps in screening...
- Federal Grant Award Summary The National Cancer Institute awarded a $122,610 Project Grant to the University of Pennsylvania on August 11, 2025, under the Cancer Treatment Research program (CFDA 93.395). The award, with a completion date of July 31, 2030, supports the development of a system to advance National Cancer Institute (NCI)-sponsored clinical trials for patients with rare gastrointestinal malignancies and rare disease populations. The project leverages the principal investigator's...
- Federal Project Grant Award Summary New York University received a $442,750 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), with performance extending from September 23, 2025 through August 31, 2027. This research initiative delivers a systematic, theory-driven analysis of implementation strategies for cervical cancer control policies in African low- and middle-income countries (LMICs). The project employs a rigorous...
- Federal Project Grant Award Summary The University of Pennsylvania received a $220,576 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) effective August 1, 2025, through July 31, 2030. This five-year initiative delivers tobacco treatment implementation (TTI) training and technical assistance to clinical change agents within healthcare organizations serving four high-impact populations: financially impoverished individuals, persons...
- Federal Grant Award Summary The University of Texas MD Anderson Cancer Center received a $825,966 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded September 4, 2025, with a completion date of August 31, 2030. The RISE (Reducing Cancer and HIV Stigma Through Empowerment) project delivers a multilevel, culturally adapted storytelling intervention designed to address dual stigma experienced by Zambian women living with...
- Federal Project Grant Award Summary Award Details: Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a $3.28 million Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393). The award was obligated on August 15, 2025, with a project completion date of July 31, 2029. Products and Services: The funded project will develop and deliver English and Spanish-language smartphone-based Embodied...
- Federal Project Grant Award Summary The National Cancer Institute awarded a $498,565 Project Grant to The University of Texas MD Anderson Cancer Center on September 8, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop a Globally Accessible and Pragmatic Predictive Signature (GAPPS) for locally advanced cervical cancer. The project, which extends through July 31, 2029, addresses a critical clinical need to risk-stratify cervical cancer patients undergoing...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Connecticut a Project Grant totaling $444,991 under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period May 1, 2026 through April 30, 2030. This grant supports a randomized controlled trial of a dissonance-based sun safety intervention designed to reduce indoor and outdoor tanning behavior among young adults ages 20-39, a population in which melanoma is the second most prevalent...